Rejnmark, L., Gosmanova, E. O., Khan, A. A., Makita, N., Imanishi, Y., Takeuchi, Y., Sprague, S., Shoback, D. M., Kohlmeier, L., Rubin, M. R., Palermo, A., Schwarz, P., Gagnon, C., Tsourdi, E., Zhao, C., Makara, M. A., Ominsky, M. S., Lai, B., Ukena, J. ... Shu, A. D. (2024).
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Advances in Therapy,
41(6), 2500-2518.
https://doi.org/10.1007/s12325-024-02843-8
Richter, M. M., Kemp, I. M.
, Heebøll, S., Winther-Sørensen, M., Kjeldsen, S. A. S., Jensen, N. J., Nybing, J. D., Linden, F. H., Høgh-Schmidt, E., Boesen, M. P., Madsbad, S., Schiødt, F. V., Nørgaard, K., Schmidt, S., Gluud, L. L., Haugaard, S. B., Holst, J. J.
, Nielsen, S., Rungby, J. & Wewer Albrechtsen, N. J. (2024).
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
Metabolism,
156, Article 155915.
https://doi.org/10.1016/j.metabol.2024.155915
Rubæk, M., Broholm-Jørgensen, M., Andersen, S., Jakobsen, P. R., Rothmann, M. J.
, Langdahl, B., Hitz, M. F. & Holmberg, T. (2024).
Development of a program theory for osteoporosis patient education in Denmark: a qualitative study based on realist evaluation.
BMC Geriatrics,
24(1), Article 346.
https://doi.org/10.1186/s12877-024-04957-8